UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

The New England journal of medicine, 2015-08, Vol.373 (8), p.737-746

2015

Volltextzugriff (PDF)

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1080-1087

2018

Volltextzugriff (PDF)

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update

European journal of cancer (1990), 2018-05, Vol.94, p.115-125

2018

Volltextzugriff (PDF)

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

Journal of clinical oncology, 2010-05, Vol.28 (13), p.2137-2143

2010

Volltextzugriff (PDF)

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3167-3175

2010

Volltextzugriff (PDF)

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3617-3622

2010

Volltextzugriff (PDF)

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5422-5428

2008

Volltextzugriff (PDF)

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3213-3221

2008

Volltextzugriff (PDF)

Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

Journal of clinical oncology, 2008-07, Vol.26 (20), p.3403-3410

2008

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3998-4003

2012

Volltextzugriff (PDF)

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1525-1530

2011

Volltextzugriff (PDF)

Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (4), p.829-836

2014

Volltextzugriff (PDF)

Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study

Journal of clinical oncology, 2010-07, Vol.28 (21), p.3491-3497

2010

Volltextzugriff (PDF)

Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Journal of clinical oncology, 2023-02, Vol.41 (4), p.715-723

2023

Volltextzugriff (PDF)

Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6657-6663

2005

Volltextzugriff (PDF)

Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3361-3367

2012

Volltextzugriff (PDF)

Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3069-3074

2006

Volltextzugriff (PDF)

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)

British journal of cancer, 2018-05, Vol.118 (11), p.1434-1441

2018

Volltextzugriff (PDF)

Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1025-1033

2004

Volltextzugriff (PDF)

Androgen Receptor Mutations in Androgen-Independent Prostate Cancer: Cancer and Leukemia Group B Study 9663

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2673-2678

2003

Volltextzugriff (PDF)

Positron tomographic assessment of androgen receptors in prostatic carcinoma

European journal of nuclear medicine and molecular imaging, 2005-03, Vol.32 (3), p.344-350

2005

Volltextzugriff (PDF)

Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors

American journal of roentgenology (1976), 2007-05, Vol.188 (5), p.1201-1207

2007

Volltextzugriff (PDF)

Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors

Journal of hematology and oncology, 2011-06, Vol.4 (1), p.29-29, Article 29

2011

Volltextzugriff (PDF)

Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2506-2513

1999

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(180)

Publikationsform

Artikel
(202)

Sprache

Englisch
(201)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Humans
(95)
Life Sciences & Biomedicine
(93)
Male
(87)
Oncology
(83)
Aged
(76)
Middle Aged
(76)
Female
(64)
Adult
(57)
Biological And Medical Sciences
(49)
Medical Sciences
(46)
Tumors
(41)
Aged, 80 And Over
(40)
Treatment Outcome
(38)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Disease-Free Survival
(26)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(22)
Survival Analysis
(18)
Drug Administration Schedule
(17)
Prostatic Neoplasms - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer

Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study

Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer

Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)

Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)

Androgen Receptor Mutations in Androgen-Independent Prostate Cancer: Cancer and Leukemia Group B Study 9663

Positron tomographic assessment of androgen receptors in prostatic carcinoma

Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors

Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors

Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

Suchergebnisse filtern